JP2005511482A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511482A5
JP2005511482A5 JP2002586732A JP2002586732A JP2005511482A5 JP 2005511482 A5 JP2005511482 A5 JP 2005511482A5 JP 2002586732 A JP2002586732 A JP 2002586732A JP 2002586732 A JP2002586732 A JP 2002586732A JP 2005511482 A5 JP2005511482 A5 JP 2005511482A5
Authority
JP
Japan
Prior art keywords
group
protonated compound
antimicrobial composition
composition
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002586732A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511482A (ja
JP4347573B2 (ja
Filing date
Publication date
Priority claimed from US09/847,654 external-priority patent/US20020032164A1/en
Application filed filed Critical
Publication of JP2005511482A publication Critical patent/JP2005511482A/ja
Publication of JP2005511482A5 publication Critical patent/JP2005511482A5/ja
Application granted granted Critical
Publication of JP4347573B2 publication Critical patent/JP4347573B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002586732A 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物 Expired - Fee Related JP4347573B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/847,654 US20020032164A1 (en) 1998-12-30 2001-05-03 Antimicrobial compounds and methods for their use
PCT/US2002/013910 WO2002089581A1 (en) 2001-05-03 2002-05-03 Antimicrobial compounds and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009120362A Division JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2005511482A JP2005511482A (ja) 2005-04-28
JP2005511482A5 true JP2005511482A5 (https=) 2005-12-22
JP4347573B2 JP4347573B2 (ja) 2009-10-21

Family

ID=25301163

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2002586732A Expired - Fee Related JP4347573B2 (ja) 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物
JP2009120362A Expired - Fee Related JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法
JP2013210031A Expired - Fee Related JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法
JP2015219286A Expired - Fee Related JP6097372B2 (ja) 2001-05-03 2015-11-09 抗菌化合物およびそれらの使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2009120362A Expired - Fee Related JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法
JP2013210031A Expired - Fee Related JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法
JP2015219286A Expired - Fee Related JP6097372B2 (ja) 2001-05-03 2015-11-09 抗菌化合物およびそれらの使用方法

Country Status (10)

Country Link
US (2) US20020032164A1 (https=)
EP (2) EP1389909B1 (https=)
JP (4) JP4347573B2 (https=)
AU (1) AU2002305336B2 (https=)
CA (2) CA2827671C (https=)
CY (1) CY1116784T1 (https=)
DK (1) DK2311466T3 (https=)
ES (1) ES2549766T3 (https=)
PT (1) PT2311466E (https=)
WO (1) WO2002089581A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
JP4999255B2 (ja) * 2001-07-10 2012-08-15 レイクウッド−アメディックス，インコーポレーテッド オリゴヌクレオチド含有薬理学的組成物およびその使用
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
LT2896397T (lt) * 2003-08-01 2017-11-27 Mitsubishi Tanabe Pharma Corporation Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį
RS20060320A (sr) * 2003-08-01 2008-08-07 Janssen Pharmaceutica N.V., Supstituisani indazol-o-glukozidi
TW200727785A (en) * 2005-11-25 2007-08-01 Maruishi Pharma Gel composition for antibacterial sterilization
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
ES2675045T3 (es) * 2007-05-04 2018-07-06 Symrise Ag Preparaciones activas sinérgicas que comprenden 1,2-decanodiol y además compuestos activos antimicrobianos
MX2010002695A (es) * 2007-09-10 2010-04-01 Janssen Pharmaceutica Nv Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
GB2460445B (en) * 2008-05-30 2012-07-11 Vernolix Ltd Treatment of ringworm
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) * 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
KR101532412B1 (ko) 2009-07-10 2015-06-29 얀센 파마슈티카 엔.브이. 1-(β-Ｄ-글루코피라노실)-4-메틸-3-(5-(4-플루오로페닐)-2-티에닐메틸) 벤젠의 결정화 방법
SI2488515T1 (sl) * 2009-10-14 2017-04-26 Janssen Pharmaceutica Nv Postopek za pripravo spojin, ki so uporabne kot inhibitorji SGLT2
TWI599360B (zh) 2010-05-11 2017-09-21 健生藥品公司 醫藥調配物
RS55056B1 (sr) 2011-04-13 2016-12-30 Janssen Pharmaceutica Nv Proces za pripremu jedinjenja koja su korisna kao inhibitori sglt2
TWI542596B (zh) 2011-05-09 2016-07-21 健生藥品公司 （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
JP6917078B2 (ja) * 2017-03-10 2021-08-11 レイクウッド アメディックス、インコーポレイテッド 抗菌化合物、組成物、及びそれらの使用
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11377468B2 (en) 2017-03-10 2022-07-05 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
FI3638251T3 (fi) 2017-06-12 2024-04-29 Lakewood Amedex Inc Bisfosfosiinin geeliformulaatioita ja niiden käyttötapoja
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
SG11202103180QA (en) 2018-10-17 2021-05-28 Lakewood Amedex Inc Methods and compositions for treating oral mucositis
CZ2019769A3 (cs) * 2019-12-12 2021-09-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. Lipofosfonoxiny třetí generace, jejich příprava a použití
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
KR20220009630A (ko) * 2020-07-16 2022-01-25 정준영 플라즈마를 이용한 마스크 폐기 처리기
CN115448967A (zh) * 2022-09-26 2022-12-09 泽同医药科技(南通)有限公司 一种吩噁嗪半乳烯糖碳苷化合物及其合成方法
WO2025179296A1 (en) * 2024-02-22 2025-08-28 Lakewood Amedex, Inc. Crystalline forms of nu-3 and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
DE2916318A1 (de) * 1979-04-23 1980-11-06 Hoechst Ag Waesserige desinfektionsloesung
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4908209A (en) * 1983-08-16 1990-03-13 Interface, Inc. Biocidal delivery system of phosphate ester and method of preparation thereof
JPS60209077A (ja) * 1984-03-27 1985-10-21 竹本油脂株式会社 繊維処理用油剤及び該油剤による合成繊維糸の処理方法
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
DE3542516A1 (de) 1985-12-02 1987-06-04 Henkel Kgaa Desinfektionsmittel
WO1989001023A1 (en) * 1987-08-03 1989-02-09 Interface Research Corporation Microbiocidal cleansing or disinfecting formulations and preparation thereof
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
ZA902710B (en) 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
DK0561948T3 (da) * 1990-12-07 1995-08-21 Upjohn Co Phosphonsyrederivater, der kan anvendes som antiinflammatoriske midler
US5681829A (en) * 1992-10-08 1997-10-28 Shaman Pharmaceuticals, Inc. Class of phosphocholine derivatives having antifungal activity
US5811568A (en) * 1992-10-08 1998-09-22 Shaman Pharmaceuticals, Inc. Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
JPH08502298A (ja) * 1992-10-08 1996-03-12 シェイマン ファーマシューティカル，インコーポレーテッド 抗真菌活性をもつ新規クラスのホスホコリン誘導体
DE4333385C2 (de) 1993-09-30 1997-01-30 Friedrich A Spruegel Flächendesinfektions- und Reinigungsmittel
FR2718022B1 (fr) 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2727289B1 (fr) * 1994-11-30 1999-03-05 Derives Resiniques Terpenique Composition desinfectante comprenant au moins un alcool terpenique et au moins un tensio-actif acide bactericide, et utilisation de tels tensio-actifs
EP0914040A1 (en) * 1995-11-28 1999-05-12 Michael D. Wider Antimicrobial composition and methods of use therefor
US5843998A (en) 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
US6211349B1 (en) * 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6610314B2 (en) * 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations

Similar Documents

Publication Publication Date Title
JP2005511482A5 (https=)
JP2009179639A5 (https=)
JP2002502874A5 (https=)
RU2001105955A (ru) Трифторметилпирролкарбоксамиды
JP2002539181A5 (https=)
KR890006602A (ko) 항균제로서 유용한 아미노메틸 옥소옥사졸리디닐 아로인벤젠 유도체
JP2005523922A5 (https=)
JP2002540208A5 (https=)
JP2013540786A5 (https=)
JP2005507004A5 (https=)
JP2009520695A5 (https=)
JP2004529953A5 (https=)
JP2004525178A5 (https=)
BR1100212A (pt) Composto pesticida de solo; processo de preparação de um composto pesticida; composição inseticida; uso de um composto; e processo de combate de pestes de insetos originários do solo.
JP2005519989A5 (https=)
JP2004502684A5 (https=)
JP2005516898A5 (https=)
DE69929362D1 (de) verwendung von 1,4-benzothiazepinen zur Herstellung eines Medikaments ZUR BEHANDLUNG DER VORHOF-FIBRILLATION
JP2007523874A5 (https=)
JP2004538314A5 (https=)
JPH1112272A5 (https=)
RU2005101201A (ru) Аминоацетонитрилбные производные, пригодные для борьбы с паразитами
JP2003509494A5 (https=)
EP1120401A3 (en) Chiral copper complex catalyst composition and asymmetric production process using the same
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung